Publikationen W. Löscher

Gailus, B., Naundorf, H., Welzel, L., Johne, M., Römermann, K., Kaila, K., & Löscher, W. (2021). Long-term outcome in a noninvasive rat model of birth asphyxia with neonatal seizures: Cognitive impairment, anxiety, epilepsy, and structural brain alterations. Epilepsia: The Journal of the International League Against Epilepsy, 0. https://doi.org/10.1111/epi.17050
Details anzeigen

Galanopoulou, A. S., Löscher, W., Lubbers, L., O’Brien, T. J., Staley, K., Vezzani, A., D’Ambrosio, R., White, H. S., Sontheimer, H., Wolf, J. A., Twyman, R., Whittemore, V., Wilcox, K. S., Klein, B., O’Brien, T. J., & D’Ambrosio, R. (2021). Antiepileptogenesis and disease modification: progress, challenges, and the path forward - Report of the Preclinical Working Group of the 2018 NINDS‐sponsored antiepileptogenesis and disease modification workshop. Epilepsia Open, 6(2), 276–296. https://doi.org/10.1002/epi4.12490
Details anzeigen

Gericke, B., Borsdorf, S., Wienböker, I., Noack, A., Noack, S., & Löscher, W. (2021). Similarities and differences in the localization, trafficking, and function of P-glycoprotein in MDR1-EGFP-transduced rat versus human brain capillary endothelial cell lines. Fluids and Barriers of the CNS, 18. https://doi.org/10.1186/s12987-021-00266-z
Details anzeigen

Hampel, P., Johne, M., Gailus, B., Vogel, A., Schidlitzki, A., Gericke, B., Töllner, K., Theilmann, W., Käufer, C., Römermann, K., Kaila, K., & Löscher, W. (2021). Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsy. Neurobiology of Disease, 152: 105297. https://doi.org/10.1016/j.nbd.2021.105297
Details anzeigen

Hampel, P., Römermann, K., Gailus, B., Johne, M., Gericke, B., Kaczmarek, E., & Löscher, W. (2021). Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice. Neuropharmacology, 185: 108449. https://doi.org/10.1016/j.neuropharm.2021.108449
Details anzeigen

Hampel, P., Römermann, K., Gramer, M., & Löscher, W. (2021). The search for brain-permeant NKCC1 inhibitors for the treatment of seizures: Pharmacokinetic-pharmacodynamic modelling of NKCC1 inhibition by azosemide, torasemide, and bumetanide in mouse brain. Epilepsy & Behavior, 114(Pt A), 107616. https://doi.org/10.1016/j.yebeh.2020.107616
Details anzeigen

Hampel, P., Römermann, K., Gramer, M., & Löscher, W. (2021). The search for brain-permeant NKCC1 inhibitors for the treatment of seizures: Pharmacokinetic-pharmacodynamic modelling of NKCC1 inhibition by azosemide, torasemide, and bumetanide in mouse brain. Epilepsy & Behavior, 114(Part A: 107616). https://www.sciencedirect.com/science/article/abs/pii/S1525505020307964?via%3Dihub
Details anzeigen

Johne, M., Käufer, C., Römermann, K., Gailus, B., Gericke, B., & Löscher, W. (2021). A combination of phenobarbital and the bumetanide derivative bumepamine prevents neonatal seizures and subsequent hippocampal neurodegeneration in a rat model of birth asphyxia. Epilepsia: The Journal of the International League Against Epilepsy, 62(6), 1460–1471. https://doi.org/10.1111/epi.16912
Details anzeigen

Johne, M., Römermann, K., Hampel, P., Gailus, B., Theilmann, W., Ala-Kurikka, T., Kaila, K., & Löscher, W. (2020). Phenobarbital and midazolam suppress neonatal seizures in a noninvasive rat model of birth asphyxia, whereas bumetanide is ineffective. Epilepsia: The Journal of the International League Against Epilepsy, 00: early access. https://doi.org/10.1111/epi.16778
Details anzeigen

Löscher, W., & Kaila, K. (2021). Reply to the commentary by Ben-Ari and Delpire: Bumetanide and neonatal seizures: fiction versus reality. Epilepsia: The Journal of the International League Against Epilepsy, 62(4), 941–946. https://doi.org/10.1111/epi.16866
Details anzeigen